#8,963 by institutional money · Stock
Polaryx Therapeutics, Inc. (PLYX)
Institutional ownership from Q3 2026 Form 13F filings
$1.37
−9.34% today
Live prices, last trade 12:17 PM ET
- 13F holders
- 13 (+0)
- Held by 13F filers, live
- $2.8M
- Shares held
- 2,075,707
- Share of stock outstanding
- 4.4%
- Net buying in Q3 2026
- −$161K
- New positions / sold out
- 2 / 2
Largest holders
13 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1,655,833 | $2.3M | <0.1% | Reduced −0% |
| Geode Capital Management, LLC | 138,757 | $190K | <0.1% | Reduced −19% |
| Vanguard Fiduciary Trust Co | 80,320 | $110K | <0.1% | Reduced −24% |
| State Street Corp | 68,004 | $93K | <0.1% | Added +17% |
| BlackRock, Inc. | 41,012 | $56K | <0.1% | Unchanged |
| HRT Financial LP | 33,103 | $45K | <0.1% | Reduced −60% |
| Northern Trust Corp | 27,987 | $38K | <0.1% | Unchanged |
| Cerity Partners LLC | 10,427 | $14K | <0.1% | New |
| Allworth Financial LP | 7,727 | $11K | <0.1% | Unchanged |
| Vanguard Global Advisers, LLC | 6,318 | $9K | <0.1% | Unchanged |
| UBS Group AG | 4,355 | $6K | <0.1% | Added +239% |
| Tower Research Capital LLC (TRC) | 1,855 | $3K | <0.1% | Reduced −38% |
| Barclays Plc | 9 | $12 | <0.1% | New |